ANI Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Dec 6, 2024
  • No warning letters matched by name
Inspections 10 0 OAI
Recalls 13 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

ANI Pharmaceuticals, Inc. has 13 FDA recalls, 10 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "ANI Pharmaceuticals, Inc." is on file.

What these totals cover: FDA records filed under the name "ANI Pharmaceuticals, Inc." and its spelling variant "Ani Pharmaceuticals".

Latest recall
D-0619-2026 · Class III · Jun 2, 2026
Latest inspection
Dec 6, 2024 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls13Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections10Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

ANI Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

ANI Pharmaceuticals, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 5 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600020
202500000
202410000
202300000
202210050
202100000
202000060
201910000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing ANI Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check ANI Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

13 recall records from Oct 9, 2020 to Jun 2, 2026.

NumberClassProductDate
D-0619-2026Class IIIhydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by…Jun 2, 2026
D-0543-2026Class IIEstradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI…May 12, 2026
D-0564-2022Class IIAlprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b) 500-count…Feb 15, 2022
D-0567-2022Class IIAlprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count…Feb 15, 2022
D-0568-2022Class IIPyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab…Feb 15, 2022
D-0566-2022Class IIAlprazolam Tablets, USP 1.0 mg, packaged in a) 100-count bottles (NDC 67253-902-10), b) 500-count…Feb 15, 2022
D-0565-2022Class IIAlprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count…Feb 15, 2022
D-0044-2021Class IIIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Oct 9, 2020
D-0047-2021Class IIIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Oct 9, 2020
D-0048-2021Class IIIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Oct 9, 2020
D-0046-2021Class IIIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Oct 9, 2020
D-0045-2021Class IIIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Oct 9, 2020
D-0043-2021Class IIIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Oct 9, 2020

Recent FDA inspections

10 inspections from Jan 28, 2010 to Dec 6, 2024.

DateSiteProductClassificationFEI
Dec 6, 2024Baudette, MNDrugsVoluntary Action Indicated (VAI)2111358
Nov 18, 2022Baudette, MNDrugsVoluntary Action Indicated (VAI)2111358
Apr 12, 2019Baudette, MNDrugsNo Action Indicated (NAI)2111358
Jul 28, 2016Baudette, MNDrugsNo Action Indicated (NAI)2111358
Sep 27, 2013Baudette, MNDrugsNo Action Indicated (NAI)2111358
Jan 6, 2012Baudette, MNDrugsVoluntary Action Indicated (VAI)2111358
Sep 16, 2011Baudette, MNDrugsVoluntary Action Indicated (VAI)2111358
Sep 15, 2011Baudette, MNDrugsNo Action Indicated (NAI)2111358
Jan 29, 2010Baudette, MNDrugsVoluntary Action Indicated (VAI)2111358
Jan 28, 2010Baudette, MNDrugsNo Action Indicated (NAI)2111358
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2111358Baudette, MN10Dec 6, 2024

ANI Pharmaceuticals, Inc. and the FDA: common questions

Has ANI Pharmaceuticals, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "ANI Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has ANI Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "ANI Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect ANI Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Dec 6, 2024 at Baudette, MN and was classified VAI. FDA has 10 inspections of ANI Pharmaceuticals, Inc. on file.

Has ANI Pharmaceuticals, Inc. had an FDA recall?

Yes. ANI Pharmaceuticals, Inc. has 13 FDA recalls on record. The most recent started Jun 2, 2026.

Need more than this page shows? Ask about ANI Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.